News & Media

Print

September 24, 2012

Announcement for the IMPC International Symposium in Tokyo

The International Mouse Phenotyping Consortium: its activity and value for biomedical sciences

RIKEN is going to hold the "IMPC International Symposium in Tokyo" in WTC Conference Center, Minato City, Tokyo from 10 am on September 28, Friday.

The International Mouse Phenotyping Consortium, IMPC, is an international collaborative research project to discover the relations between human and mammalian genome and phenotypes - physiological or behavioral characters such as blood elements or auditory and visual perception - using mice as a model.

World leading mouse resource organizations are taking charge of certain number of knockout mouse strains for each to produce live mice, phenotype them in line with the protocols agreed in IMPC, and aggregate and publish the data on the standardized forms.

RIKEN BioResource Center (RIKEN BRC) has joined IMPC since its launch in 2011 and taken a leading role in the standardizing protocols as a representative mouse resource center in Asia.

In this symposium, core members of IMPC and key people from the life science research and drug development in Japan are invited to give a speech and have a discussion on how to utilize IMPC phenotyping data and resources for basic life sciences and prevention, diagnosis and treatment of diseases.

Outline

Date & Time

10:00 - 17:00, September 28, 2012

Place

WTC Conference Center (Hamamatsu-cho, Tokyo)
(The room "Fontaine", 38th floor of the World Trade Center Building)

Target Audience

Anyone interested in life sciences and drug development
(Admission free / Capacity: 200 people)

Language

English

Organizers

RIKEN, The International Mouse Phenotyping Consortium (IMPC)

Registration

Please register on http://impc.brc.riken.jp/en/

Program

10:00 - 10:20
Opening Remarks
Yuichi Obata (Director of RIKEN BRC)
Opening Addresses
Kenji Oeda (Executive Director of RIKEN)
Tomohiko Arai (MEXT)
10:20 - 12:00
Session I Overview of IMPC
1. Overview
Mark Moore (Executive Director, IMPC)
2. KOMP2
Colin Fletcher (National Institute of Health, USA)
3. MPI2
Hiroshi Masuya (RIKEN BRC)
4. Japan Mouse Clinic
Shigeharu Wakana (RIKEN BRC)
13:00 - 13:50
Session II The Value for Basic Sciences
Monica Justice (Baylor College of Medicine, USA)
Toshihiko Shiroishi (National Institute of Genetics)
13:50 - 14:40
Session III The Value for Drug Discovery
Tom Weaver (MRC Harwell, UK)
Yoichi Nabeshima (Foundation for Biomedical Research and Innovation)
14:40 - 15:00 Break
15:00 - 15:40
Session IV Distribution of Mouse Knockout Resources
Prof. Kent Lloyd (UC Davis, USA)
Atsushi Yoshiki (RIKEN BRC)
15:40 - 16:50
Session V Panel Discussion
"How to Utilize IMPC Phenotyping Data and IKMC Resources"
16:50 - 17:00
Closing Remarks
Kazuo Moriwaki (RIKEN BRC)